Medical insurance price of Ustekinumab

Ustekinumab (Ustekinumab)The original drug has been launched in China and is included in medical insurance. It is only reimbursed for patients who meet the indications. Specifications130mg/26ml intravenous injection The price of each box of 90mg: 1.0ml*1 subcutaneous injection preparation may be more than 8,000 RMB. The reimbursement ratio is different in different regions, and the price after reimbursement may be slightly different. For specific information, please consult the local medical insurance bureau or hospital.

Ustekinumab contains the active substanceustekinumab, an immunosuppressant and a human IgG1 monoclonal antibody against the p40 subunit of interleukin-12 (IL-12) and interleukin-23 (IL-23). Ustekinumab is used to treat psoriasis, which includes psoriatic arthritis that affects the skin. Ustekinumab is indicated for the treatment of adult and adolescent patients (12 years and older) with moderate to severe plaque psoriasis (Ps) who may require phototherapy or systemic therapy, and adults with active psoriatic arthritis (PsA), alone or in combination with methotrexate. It is also used to treat moderately to severely active Crohn's disease and moderately to severely active ulcerative colitis.

The specifications of ustekinumab’s original drug sold overseasThe price of 130mg/26ml intravenous preparation may be more than 2,000 US dollars per box, and the price of 45mg: 0.5ml*1 subcutaneous injection preparation may be more than 10,000 US dollars per box. There are currently no generic versions of ustekinumab produced in other overseas countries. For more overseas drugs specific prices and details, please consult Yaode Medical Consultant.